ES8401935A1 - "procedimiento para la preparacion de beta-lactamas". - Google Patents

"procedimiento para la preparacion de beta-lactamas".

Info

Publication number
ES8401935A1
ES8401935A1 ES515255A ES515255A ES8401935A1 ES 8401935 A1 ES8401935 A1 ES 8401935A1 ES 515255 A ES515255 A ES 515255A ES 515255 A ES515255 A ES 515255A ES 8401935 A1 ES8401935 A1 ES 8401935A1
Authority
ES
Spain
Prior art keywords
preparation
lactams
beta
optically uniform
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515255A
Other languages
English (en)
Other versions
ES515255A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES515255A0 publication Critical patent/ES515255A0/es
Publication of ES8401935A1 publication Critical patent/ES8401935A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Fats And Perfumes (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE BETA-LACTAMAS, OPTICAMENTE UNIFORMES, DE FORMULA GENERAL (I), EN LA QUE R REPRESENTA AMINO O UN GRUPO CONVERTIBLE EN AMINO; R REPRESENTA HIDROGENO O UN GRUPO PROTECTOR FACILMENTE DISOCIABLE; RA ES UN GRUPO CARACTERISTICO; Y R Y R REPRESENTAN, CADA UNO DE ELLOS UN GRUPO HIDROCARBURICO INFERIOR QUE CONTIENE OXIGENO, Y SUS ANTIPODAS OPTICOS CORRESPONDIENTES.CONSISTE EN HACER REACCIONAR UN DERIVADO REACTIVO DE UN ACIDO CARBOXILICO, DE FORMULA GENERAL: R-CH2-COOH, EN LA QUE R REPRESENTA AZIDO O FTALIMIDO, EN PRESENCIA DE UNA BASE,CON UN COMPUESTO OPTICAMENTE UNIFORME DE FORMULA GENERAL (II), EN LA QUE R Y R TIENEN EL SIGNIFICADO YA INDICADO; Y Z REPRESENTA UN GRUPO PROTECTOR FACILMENTE DISOCIABLE.DE APLICACION COMO PRODUCTOS INTERMEDIARIOS PARA LA PREPARACION DE SUSTANCIAS FARMACEUTICAS ACTIVAS.
ES515255A 1981-08-27 1982-08-26 "procedimiento para la preparacion de beta-lactamas". Expired ES8401935A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH552481 1981-08-27
CH392582 1982-06-25

Publications (2)

Publication Number Publication Date
ES515255A0 ES515255A0 (es) 1984-01-16
ES8401935A1 true ES8401935A1 (es) 1984-01-16

Family

ID=25694185

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515255A Expired ES8401935A1 (es) 1981-08-27 1982-08-26 "procedimiento para la preparacion de beta-lactamas".

Country Status (15)

Country Link
US (3) US4576751A (es)
EP (2) EP0156976B1 (es)
KR (1) KR880000432B1 (es)
AT (2) ATE25676T1 (es)
AU (2) AU555097B2 (es)
CA (1) CA1262128A (es)
DE (2) DE3277410D1 (es)
DK (1) DK168433B1 (es)
ES (1) ES8401935A1 (es)
HU (1) HU190697B (es)
IE (1) IE53791B1 (es)
IL (1) IL66619A0 (es)
NO (1) NO159931C (es)
NZ (1) NZ201660A (es)
PH (1) PH21581A (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782147A (en) * 1980-12-05 1988-11-01 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
US4572801A (en) * 1981-04-30 1986-02-25 Takeda Chemical Industries, Ltd. 4-Carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
EP0096296B1 (de) * 1982-06-03 1987-07-29 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft 1-Sulfo-2-oxoazetidinderivate
CA1204746A (en) * 1982-08-19 1986-05-20 Hoffmann-La Roche Limited .beta. LACTAMS
US4502994A (en) * 1982-12-09 1985-03-05 Hoffmann-La Roche Inc. Enantiomeric synthesis of 3-amino-4-carbamoyloxymethyl-2-azetidonone-1-sulfate
US4663469A (en) * 1982-12-09 1987-05-05 Hoffman-La Roche Inc. 4-hydroxy-l-threoninamides
CA1251454A (en) * 1983-01-20 1989-03-21 Gerard Schmid PROCESS FOR THE MANUFACTURE OF .beta.-LACTAMES
DK36784A (da) * 1983-02-25 1984-08-26 Hoffmann La Roche Fremgangsmaade til fremstilling af chirale aldehyder
US4501697A (en) * 1983-06-17 1985-02-26 E. R. Squibb & Sons, Inc. 4-[[(Amidomethyl)oxy]methyl]-2-oxo-1-azetidinesulfonic acid salts
DK411384A (da) * 1983-10-03 1985-04-04 Hoffmann La Roche Fremgangsmaade til fremstilling af azetidinonderivater
EP0146735A1 (de) * 1983-11-23 1985-07-03 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Optisch einheitliche beta-Lactame
JPS60139667A (ja) * 1983-12-27 1985-07-24 Takeda Chem Ind Ltd アゼチジノンの製造法
GB8717446D0 (en) * 1987-07-23 1987-08-26 Merck Sharp & Dohme Chemical compounds
US4937331A (en) * 1988-03-25 1990-06-26 President And Fellows Of Harvard College Chiral azetidinone epoxides
PT2197881E (pt) * 2007-09-17 2013-06-28 Basilea Pharmaceutica Ag Processo para o fabrico de intermediários monobactama em ponte
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
CN103044416A (zh) * 2012-12-17 2013-04-17 浙江华方药业有限责任公司 一种卡芦莫南钠的合成方法
WO2015148379A1 (en) 2014-03-24 2015-10-01 Novartis Ag Monobactam organic compounds for the treatment of bacterial infections
CN108137573B (zh) 2015-09-23 2021-06-11 诺华股份有限公司 单环内酰胺抗生素的盐和固体形式
WO2019026004A2 (en) 2017-08-02 2019-02-07 Novartis Ag CHEMICAL PROCESS FOR THE PREPARATION OF ANTIBIOTIC MONOBACTAM AND ITS INTERMEDIATES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK194776A (da) * 1975-05-05 1976-11-06 Smithkline Corp Antibakterielle midler og mellemprodukter dertil
GB1570278A (en) * 1975-10-06 1980-06-25 Fujisawa Pharmaceutical Co O-substituted-2-azetidinone derivatives and the preparation thereof
JPS609514B2 (ja) * 1976-08-05 1985-03-11 塩野義製薬株式会社 ７−アミノ−３′−ノルセファロスポラン酸類
US4202978A (en) * 1978-02-08 1980-05-13 Hoffmann-La Roche Inc. (S)-1-[2-(4-(2-Hydroxy-s-(1-alkylaminopropoxy)phenylalkyl]-4-phenylpiperazines
US4473502A (en) * 1981-04-08 1984-09-25 Merck & Co., Inc. Synthesis of thienamycin via (3SR, 4RS)-3-[1 (SR)-hydroxyethyl]-2-oxo-4-azetidineacetic acid

Also Published As

Publication number Publication date
DE3275543D1 (en) 1987-04-09
PH21581A (en) 1987-12-11
KR840001135A (ko) 1984-03-28
DK168433B1 (da) 1994-03-28
NO159931B (no) 1988-11-14
IE822067L (en) 1983-02-27
DK373082A (da) 1983-02-28
EP0156976B1 (de) 1987-09-30
US4699986A (en) 1987-10-13
EP0156976A2 (de) 1985-10-09
CA1262128A (en) 1989-10-03
ATE30017T1 (de) 1987-10-15
KR880000432B1 (ko) 1988-03-24
EP0073061A3 (en) 1983-06-15
AU576951B2 (en) 1988-09-08
AU555097B2 (en) 1986-09-11
ES515255A0 (es) 1984-01-16
EP0156976A3 (en) 1986-06-04
AU5467186A (en) 1986-07-31
US4576751A (en) 1986-03-18
IE53791B1 (en) 1989-02-15
AU8752382A (en) 1983-03-03
HU190697B (en) 1986-10-28
EP0073061A2 (de) 1983-03-02
US4617150A (en) 1986-10-14
DE3277410D1 (en) 1987-11-05
IL66619A0 (en) 1982-12-31
EP0073061B1 (de) 1987-03-04
ATE25676T1 (de) 1987-03-15
NO822902L (no) 1983-02-28
NO159931C (no) 1989-02-22
NZ201660A (en) 1986-01-24

Similar Documents

Publication Publication Date Title
ES8401935A1 (es) "procedimiento para la preparacion de beta-lactamas".
GR1000918B (el) Μέ?οδος δια την παρασκευήν φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροϊών.
ATE68468T1 (de) (meth)-acrylsaeureester.
DK0435321T3 (da) Nye A-nor-steroid-3-carboxylsyrederivater
CU22305A3 (es) Procedimiento para la preparacion de un derivado de aminoacidos
ES2147230T3 (es) Derivados de aminoacidos, medicamentos que contienen a estos compuestos y procedimiento para su preparacion.
ES480109A1 (es) Procedimkiento para la preparacion de derivados de imidazo- lidina.
ES2054826T3 (es) Peptidos con actividad inhibidora de colagenasa.
ES8602022A1 (es) Un procedimiento para preparar un derivado de 4'-dimetil-4-epipodofilotoxina
ES2101382T3 (es) Acido 2-ceto-3-metil-4-hidroxi-valerianico.
AU6319480A (en) 2-hydroxyalkyl-3,4,5-trihydroxypiperidines
PT89788A (pt) Processo de preparacao de derivados da quinolina substituidas e de composicoes farmaceuticas que os contem
ES8202015A1 (es) Un procedimiento para la preparacion de derivados de penici-lina
ES8706692A1 (es) Un metodo para preparar nuevos derivados de cefem
AU6216886A (en) Substituted 2-cyano-2-phenyl ethyl-amine
ES8400772A1 (es) "proceso para preparar insulina humana o los esteres b-30 de la misma".
ES8307820A1 (es) Procedimiento para la obtencion de esteres del acido 7b-2-(2amino-4-tiazolil)-2-(sin)-metoxiiminoacetamido-3-cefem-4-carboxilico.
ES8106482A1 (es) Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos
ES8301235A1 (es) Un procedimiento para la preparacion de nuevos acilderivadosde cefalosporina
ES8202818A1 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
ES8800952A1 (es) Un procedimiento para la preparacion de derivados de carbapenem.
DK645589A (da) Arolyxopropanolaminotetraliner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
ES2052493T3 (es) Utilizacion de inhibidores de girasa para la descontaminacion de cultivos celulares infectados con micoplasma.
IL87561A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
ES483087A1 (es) Procedimiento para la obtencion de bencimidazolcarbamatos